Stay updated on Pembrolizumab for Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.6 replaces v3.6.5 as the page's revision label. This indicates a small, behind-the-scenes update to the site version without visible changes to content or functionality.SummaryDifference0.1%

- Check20 days agoChange DetectedAugust 2026 dates were added to the Study Record Dates and older July dates were removed, reflecting an update to the revision history for NCT03603223.SummaryDifference0.2%

- Check34 days agoChange DetectedFooter revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update. No changes to study content or user actions.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study record's update dates were modified. Three new timestamps were added (2026-07-07, 2026-07-09, 2028-08-01) and three older timestamps were removed (2025-07-28, 2025-07-30, 2026-08-01).SummaryDifference0.3%

- Check70 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.